Начало › Рак на панкреаса › Мисури › St. Louis
Клинични проучвания за Рак на панкреаса в St. Louis, MO
33 проучвания за Рак на панкреаса търсят участници в обекти в и около St. Louis (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
The Vanguard Study: Testing a New Way to Screen for Cancer
Набиране на участнициЗдравите доброволци са добре дошли
- Washington University School of Medicine, St Louis
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Набиране на участнициФаза 1
- Washington University School of Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набиране на участнициФаза 1
- Washington University School of Medicine in St. Louis, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 2
- Washington University, School of Medicine, St Louis
A Study of PHN-012 in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1
- PHN-012-001 Site, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Набиране на участнициНаблюдателно проучване
- Washington University, St Louis
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Набиране на участнициФаза 2/3
- Cancer Care Specialists of Illinois - Cancer Care Center of O'Fallon, O'Fallon · на 16 мили
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Набиране на участнициФаза 3
- The Alvin J. Siteman Cancer Center - Center for Advanced Med, St Louis
- Mercy David C. Pratt Cancer Center - St. - Mercy Research - David C. Pratt Cancer Center, St Louis
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Набиране на участнициФаза 2
- Siteman Cancer Center (Washington University School of Medicine), St Louis
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Набиране на участници
- Siteman Cancer Center Washington University, St Louis
Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Набиране на участнициФаза 1
- Washington University School of Medicine, St Louis
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Набиране на участнициНаблюдателно проучване
- Washington University School of Medicine, St Louis
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Набиране на участници
- Washington University, St. Louis, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Washington University School of Medicine, St Louis
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Набиране на участнициНаблюдателно проучване
- Washington University School of Medicine, St Louis
- Missouri Baptist Medical Center, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · на 16 мили
- и още 1
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Набиране на участнициФаза 2
- Washington University, St Louis
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Набиране на участнициФаза 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- и още 2
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Набиране на участнициФаза 3
- Cancer Care Center of O'Fallon, O'Fallon · на 16 мили
- HSHS Saint Elizabeth's Hospital, O'Fallon · на 16 мили
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
Набиране на участници
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
Набиране на участнициФаза 1
- Washington University School of Medicine, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Investigative Site #110, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Набиране на участнициФаза 1/2
- Washington University, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набиране на участнициФаза 1
- Research Site, St Louis
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Набиране на участнициФаза 3
- Missouri Baptist Medical Center, St Louis
- BJC Outpatient Center at Sunset Hills, Sunset Hills · на 13 мили
- Cancer Care Center of O'Fallon, O'Fallon · на 16 мили
- и още 1
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Набиране на участнициФаза 1
- Washington University School of Medicine, St Louis
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Washington University School of Medicine, St Louis
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Набиране на участнициФаза 2
- Washington University School of Medicine, St Louis
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Набиране на участнициФаза 3
- Missouri Baptist Medical Center, St Louis
- BJC Outpatient Center at Sunset Hills, Sunset Hills · на 13 мили
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Washington University, St Louis
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Набиране на участнициФаза 2
- Ohio State University-Telemedicine, St Louis
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Набиране на участнициФаза 1/2
- Washington University, St Louis
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Набиране на участнициНаблюдателно проучване
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- BJC Outpatient Center at Sunset Hills, Sunset Hills · на 13 мили
- и още 3
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, St Louis
Проучвания за Рак на панкреаса в други градове
- Houston, TX61 проучвания
- New York City, NY60 проучвания
- Boston, MA43 проучвания
- Nashville, TN39 проучвания
- Los Angeles, CA35 проучвания
- Arlington, VA33 проучвания
- Baltimore, MD31 проучвания
- San Antonio, TX31 проучвания
- Philadelphia, PA26 проучвания
- Tampa, FL26 проучвания
- Durham, NC24 проучвания
- San Diego, CA24 проучвания
Други проучвания в St. Louis
- Рак на белия дроб с недребноклетъчен тип73 проучвания
- Рак на гърдата64 проучвания
- Метастатичен рак54 проучвания
- Колоректален рак50 проучвания
- Рак (всички видове)46 проучвания
- Рак на простатата46 проучвания
- Рак на белия дроб39 проучвания
- Рак на яйчниците38 проучвания
- Ендометриален рак29 проучвания
- Плоскоклетъчен карцином на главата и шията28 проучвания
- Сърдечна недостатъчност26 проучвания
- Затлъстяване25 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.